.png "1(8).png")
From January 30 to February 1, CHAMEDITECH participated in the ‘IMCAS (International Master Course on Aging Skin) World Congress 2025 (hereinafter referred to as IMCAS Paris)’ held in Paris, France, and promoted the excellence of its self-developed HA filler and Skin Booster.
IMCAS Paris, which is in its 26th year this year, is considered one of the world’s top three aesthetic plastic surgery conferences. Approximately 18,000 dermatologists, experts, and industry insiders from 136 countries participated in this event.
At this IMCAS Paris, CHAMEDITECH promoted its HA (hyaluronic acid) filler product line, ‘HyaFilia SMV’ and ‘Dorothy’, as well as its Skin Booster product, to medical professionals and industry insiders from Europe and the Middle East.
.jpg "2-horz(1).jpg")
CHAMEDITECH focused on promoting the excellence of its products through various lectures at IMCAS Paris. On the first day of the event, January 30 (local time), a symposium on HA fillers was held under the theme of ‘The Latest Trend in Integrative Procedure for Skin Radiance and Volume Restoration’.
Approximately 50 medical professionals and related personnel from the Middle East, Europe, Asia, the Middle East, and South America attended the symposium. Dr. Khalid Alshahrani from Saudi Arabia gave a presentation and introduced the treatment protocol and clinical cases for HA filler products HyaFilia and Dorothy, which can solve two concerns at once: skin radiance and volume.
In the relay lecture program ‘PRP and exosomes’ hosted by the IMCAS Paris office, CHAMEDITECH ’s skin booster ‘CELLTERMI REVIVE NX’ was introduced. Dr. Oksana Blyshcuk from Ukraine gave a lecture on the topic of ‘Restore skin & hair pigment discolorations with exosomes: To be or not to be?’ and introduced the excellence of CELLTERMI REVIVE NX.
.jpg "4(1).jpg")
CHAMEDITECH also invited 50 medical professionals from Turkey and held an exchange event to introduce the ‘Dorothy’ product. In addition, it set up an exhibition booth throughout IMCAS Paris and held business meetings with buyers and stakeholders from all over the world to seek additional opportunities for overseas expansion.
CHAMEDITECH is actively targeting overseas markets. In 2024, it launched HA fillers in Thailand, China, and Brazil, and Skinbooster in Europe, including Poland and Ukraine. In 2025, it aims to expand its global filler market share by launching HA fillers in five additional countries, including Europe and the Middle East.
To this end, CHAMEDITECH plans to participate in the ‘2025 Dubai Derma’ exhibition held in Dubai, United Arab Emirates (UAE) in April to introduce HyaFilia and CETLLERMI REVIVE NX to the Middle East and discover new buyers.
CHAMEDITECH CEO Kim sok-jin said, “We will continue to build a reputation as a global bio-aesthetics company by engaging in sales, marketing, and brand communication targeting medical professionals and related parties around the world.”